Skip to content

Clinical trials

Phase 2 Kidney Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Phase: Phase 2 Country / region: United States Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20054
20064
20071
20084
20092
20104
20114
20121
20141
20156
20163
20176
20183
20196
20202
20213
20222
20234
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Terminated9
Recruiting6
Unknown status2
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
Allena Pharmaceuticals3
Novartis Pharmaceuticals3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Akebia Therapeutics2
Goldfinch Bio, Inc.2
University of Michigan2
University of Washington2
3-C Institute for Social Development1
AMAG Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases67
Renal Insufficiency, Chronic12
Urologic Diseases10
Glomerulonephritis8
Proteinuria8
Diabetes Mellitus7
Glomerulonephritis, IGA7
Hypertension7
Nephritis7
Renal Insufficiency7

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.